Expect a priced offering announcement within 1-2 days. The dilutive overhang will pressure the stock until the offering terms (size, price, discount) are disclosed. Traders should watch for the prospectus (424B4) for exact share count and price; any discount to market will accelerate selling. Given the micro-cap status, the offering may be structured as a registered direct or at-the-market (ATM) facility.
Price Chart
Executive Summary
Curis Inc.'s S-1 registration statement (File No. 333-298203) was declared effective by the SEC on August 12, 2026, under the 1933 Act. This allows the company to proceed with a securities offering, which for a micro-cap biotech with a $5M market cap is likely a dilutive follow-on or at-the-market offering. The effectiveness creates immediate dilution overhang for existing common shareholders, as the company can now sell shares to raise capital.
Key Facts
- SEC declared effective Curis Inc.'s S-1 registration statement (File No. 333-298203) on August 12, 2026.
- The effectiveness allows Curis to sell securities under the 1933 Act, typically a dilutive follow-on offering for a micro-cap biotech.
- Curis has a market capitalization of approximately $5M, making any new share issuance materially dilutive.
- The company is a clinical-stage biotech (SIC 2836) with no disclosed revenue or product sales in the filing.
Financial Impact
Undisclosed amount; the S-1 registration does not specify the size or price of the offering. Given the $5M market cap, even a modest offering (e.g., $1-2M) would be highly dilutive to existing shareholders.
Risk Factors
- Immediate dilution from new share issuance could depress stock price by 10-30% depending on offering size and discount.
- No disclosed use of proceeds or business update — the offering may signal cash burn concerns and a need for emergency capital.
- Micro-cap biotech with $5M market cap faces high delisting risk if Nasdaq minimum bid price or market value requirements are not met.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-002653 |
| Document: 9999999995-26-002653-index.html | 9999999995-26-002653 |
| Document: 9999999995-26-002653.txt | 9999999995-26-002653 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 13, 2026 7w ago | EFFECT | $1.87 $1.13 | ▲ +39.57% | ▲ +37.83% | $0.8034 (+57.04%) |
Jul 30, 2026 9w ago | 8-K | $5.02 $1.49 | ▼ −70.32% | ▼ −73.31% | $0.8034 (−84.00%) |
Jul 2, 2026 13w ago | 8-K | $0.3466 $4.96 | ▲ +1331.04% | ▲ +1331.46% | $0.8034 (+131.79%) |
May 22, 2026 19w ago | 8-K | $9.80 $6.80 | ▲ +30.61% | ▲ +28.55% | $0.8034 (+91.80%) |
May 12, 2026 20w ago | 8-K | $10.00 $8.60 | ▲ +14.00% | ▲ +13.39% | $0.8034 (+91.97%) |
May 1, 2026 22w ago | 8-K | $11.60 $10.00 | ▲ +13.79% | ▲ +19.58% | $0.8034 (+93.07%) |
Mar 23, 2026 27w ago | EFFECT | $0.7400 $0.6000 | ▼ −18.92% | ▼ −26.34% | $0.8034 (+8.57%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access